Previous Close | €210.10 |
AI Value | €88.73 |
Upside potential | -58% |
Sartorius AG is a leading international pharmaceutical and laboratory equipment supplier, specializing in bioprocessing solutions and laboratory products. The company operates through two main segments: Bioprocess Solutions (filtration, fermentation, and purification technologies for biopharmaceutical manufacturing) and Lab Products & Services (laboratory balances, pipettes, and consumables). Sartorius holds a strong market position in the life sciences sector, particularly in biologics and cell-based therapies, supported by its technological expertise and global distribution network. Its competitive advantages include high-quality, specialized products, long-term customer relationships, and a focus on innovation-driven growth.
Active R&D focus on single-use bioprocessing technologies, advanced filtration systems, and digital solutions for lab automation. Holds numerous patents in bioprocessing and lab equipment.
Sartorius AG is well-positioned to benefit from long-term growth in biopharmaceutical manufacturing and life sciences research, supported by its innovative product portfolio and high margins. However, investors should monitor competitive pressures, regulatory hurdles, and supply chain risks. The stock suits growth-oriented investors with a medium-to-long-term horizon.
Sartorius AG Annual Report 2022, Investor Presentations, Bloomberg Industry Reports.
Historical valuation data is not available at this time.